ASH 2023 | Flow cytometry can detect changes in protein expression throughout the evolution of WM
Zachary Hunter
• 10 Dec 2023
Zachary Hunter, PhD, Dana-Farber Cancer Institute, Boston, MA, presents a study employing flow cytometry to validate findings from a multi-omic investigation that identified key genes involved in Waldenström’s macroglobulinemia (WM) evolution. Dr Hunter notes that this could lead to the development of an assay allowing clinicians to pinpoint a patient’s stage in disease progression. This interview took place at the 65th ASH Annual Meeting and Exposition, held in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
